The Scientific World Journal

The Scientific World Journal / 2007 / Article
Special Issue

Cardiac Development

View this Special Issue

Review Article | Open Access

Volume 7 |Article ID 426903 | https://doi.org/10.1100/tsw.2007.87

Kersti K. Linask, Michael VanAuker, "A Role for the Cytoskeleton in Heart Looping", The Scientific World Journal, vol. 7, Article ID 426903, 19 pages, 2007. https://doi.org/10.1100/tsw.2007.87

A Role for the Cytoskeleton in Heart Looping

Academic Editor: Robert E. Poelmann
Received31 Oct 2006
Revised17 Jan 2007
Accepted23 Jan 2007

Abstract

Over the past 10 years, key genes involved in specification of left-right laterality pathways in the embryo have been defined. The read-out for misexpression of laterality genes is usually the direction of heart looping. The question of how dextral looping direction occurred mechanistically and how the heart tube bends remains unknown. It is becoming clear from our experiments and those of others that left-right differences in cell proliferation in the second heart field (anterior heart field) drives the dextral direction. Evidence is accumulating that the cytoskeleton is at the center of laterality, and the bending and rotational forces associated with heart looping. If laterality pathways are modulated upstream, the cytoskeleton, including nonmuscle myosin II (NMHC-II), is altered downstream within the cardiomyocytes, leading to looping abnormalities. The cytoskeleton is associated with important mechanosensing and signaling pathways in cell biology and development. The initiation of blood flow during the looping period and the inherent stresses associated with increasing volumes of blood flowing into the heart may help to potentiate the process. In recent years, the steps involved in this central and complex process of heart development that is the basis of numerous congenital heart defects are being unraveled.


More related articles

 PDF Download Citation Citation
 Order printed copiesOrder
Views117
Downloads659
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.